Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device

To characterize the clinical outcomes of Angio-Seal VIP with St. Jude Medical (SJM) collagen through the collection of device/procedure-related major vascular complications and time to hemostasis.

Inclusion Criteria:

• Patient requires closure of femoral artery puncture resulting from arterial access procedure.
• Patient is ≥18 years of age.
• Patient is willing to provide written informed consent prior to study device use.
• Patient is willing and able to adhere to data collection and follow-up requirements.

Exclusion Criteria:

• Patient is participating in another clinical trial which has the potential to impact hemostasis.
• Patient has an active groin infection or systemic infection.
• Patient has undergone a vascular access procedure within the past 90 days.
• Patient has been previously enrolled in the study. (For patients undergoing multiple interventions within a timeframe of 90 days, only the initial procedure may constitute a study enrollment.)